Triple combination of lomustine, temozolomide and irradiation reduces canine glioma cell survival in vitro.
Daniel FuchsCarla Rohrer BleyLuca MorandiCaterina TononMathias S WeylandKatarzyna J NytkoPublished in: Veterinary medicine and science (2023)
Our findings indicate that combining CCNU with TMZ-irradiation significantly reduces canine glioma cell survival. Such a combination could overcome current challenges of therapeutic resistance to improve overall patient survival.
Keyphrases